[Activity tarification and national guidelines for the proper use of expensive and innovative drugs in internal medicine]

Rev Med Interne. 2008 Feb;29(2):84-6. doi: 10.1016/j.revmed.2007.05.033. Epub 2007 Jun 21.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Protocols
  • Drug Labeling
  • Drugs, Investigational / therapeutic use*
  • France
  • Humans
  • Internal Medicine*
  • Legislation, Drug
  • Marketing of Health Services*
  • Practice Guidelines as Topic*
  • Risk Assessment

Substances

  • Drugs, Investigational